Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

ClinicalTrials.gov ID: NCT07458269

Public ClinicalTrials.gov record NCT07458269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to determine the effects of ribupatide administered by subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.

Study identification

NCT ID
NCT07458269
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kailera
Industry
Enrollment
264 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2026 (Actual)
Primary completion
May 2027 (Estimated)
Completion
Jun 2027 (Estimated)
Last update posted
Jul 15, 2026

2026 – 2027

United States locations

U.S. sites
35
U.S. states
16
U.S. cities
34
Facility City State ZIP Site status
Kailera Clinical Site Mesa Arizona 85213 —
Kailera Clinical Site Sun City West Arizona 85375 —
Kailera Clinical Site Irvine California 92614 —
Kailera Clinical Site Lake Forest California 92630 —
Kailera Clinical Site Lomita California 90717 —
Kailera Clinical Site Long Beach California 90815 —
Kailera Clinical Site Montclair California 91763 —
Kailera Clinical Site Rolling Hills Estates California 90274 —
Kailera Clinical Site San Diego California 92103 —
Kailera Clinical Site Santa Ana California 92704 —
Kailera Clinical Site Van Nuys California 91405 —
Kailera Clinical Site DeLand Florida 32720 —
Kailera Clinical Site Orlando Florida 32801 —
Kailera Clinical Site Orlando Florida 32803 —
Kailera Clinical Site The Villages Florida 32162 —
Kailera Clinical Site Decatur Georgia 30030 —
Kailera Clinical Site Woodstock Georgia 30189 —
Kailera Clinical Site Morton Illinois 61550 —
Kailera Clinical Site Indianapolis Indiana 46254 —
Kailera Clinical Site Louisville Kentucky 40213 —
Kailera Clinical Site Rockville Maryland 20852 —
Kailera Clinical Site St Louis Missouri 63141 —
Kailera Clinical Site Lincoln Nebraska 68516 —
Kailera Clinical Site Omaha Nebraska 68144 —
Kailera Clinical Site East Syracuse New York 13057 —
Kailera Clinical Site Greensboro North Carolina 27405 —
Kailera Clinical Site Monroe North Carolina 28112 —
Kailera Clinical Site Raleigh North Carolina 27612 —
Kailera Clinical Site Greenville South Carolina 29607 —
Kailera Clinical Site Myrtle Beach South Carolina 29572 —
Kailera Clinical Site Knoxville Tennessee 37909 —
Kailera Clinical Site Memphis Tennessee 38119 —
Kailera Clinical Site Garland Texas 75043 —
Kailera Clinical Site San Antonio Texas 78215 —
Kailera Clinical Site Winchester Virginia 22601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07458269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07458269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →